AbCellera Biologics (ABCL) PT Raised to $15 at BMO Capital
BMO Capital analyst Gary Nachman ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
